Novonesis A/S

NSIS B

DK0060336014

Specialty Chemicals

Real-time Estimate Cboe Europe Other stock markets 13:56:30 16/07/2024 BST			5-day change	1st Jan Change
427 ^DKK	-0.52%		-0.26%	+15.14%

06-18	Transcript : Novozymes A/S - Analyst/Investor Day
06-18	European shares advance ahead of inflation data, more c.bank speakers	RE

Novozymes and Chr. Hansen receive binding tax ruling that the proposed merger can be completed as a tax-exempt merger

January 24, 2023 at 03:53 pm

Please read the announcement in the attachment

Attachment

2023_Tax-exempt_merger_ruling

Latest news about Novonesis A/S

Transcript : Novozymes A/S - Analyst/Investor Day	06-18
European shares advance ahead of inflation data, more c.bank speakers	06-18	RE
NOVONESIS : Key segments outperform in average Q1 24 showing	05-10
Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024	05-03
Novonesis Provides Sales Guidance for the Year 2024	05-03	CI
Novozymes A/S Approves Dividend for the Last Four Months Ended December 31, 2023	04-30	CI
Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	04-08	CI
China to speed up 'new productive forces', vice president says	03-26	RE
Nordic Shares Rose Thursday; Embracer Group Series B Topped Leaders	03-21	DJ
Transcript : Novozymes A/S, 2024 Guidance/Update Call, Mar 21, 2024	03-21
Novonensis expects 2024 adjusted EBITDA margin of 35%	03-21	RE
Novonesis Provides Earnings Guidance for the Year 2024	03-21	CI
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development	03-18	MT
Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG	03-18	CI
FMC Partners With Novonesis in Canada for Biosolution Products	03-12	MT
Novonesis to Unveil Fit-for-Food Mood-Support Probiotic at Natural Product Expo West	03-07	CI
Novozymes A/S Announces Board Appointments	03-04	CI
Transcript : Novozymes A/S - Shareholder/Analyst Call	03-04
Novo Nordisk's controlling shareholder plans to invest about $35 billion by 2030	02-12	RE
Novozymes A/S Reports Earnings Results for the Full Year Ended December 31, 2023	02-08	CI
NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments	02-08
Novozymes, Chr. Hansen Complete Merger Settlement	02-02	MT
Transcript : Novozymes A/S, 2023 Earnings Call, Feb 01, 2024	02-01
Novozymes Completes Merger with Chr. Hansen After Securing Final Registration, Issuing B Shares	01-29	MT
Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S.	01-28	CI

Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).

Sector

Specialty Chemicals

Calendar

27/08/2024 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

NOVONESIS : Key segments outperform in average Q1 24 showing

May 10, 2024 at 05:32 pm

More Strategies

Ratings for Novonesis A/S

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

429.3 DKK

Average target price

455.6 DKK

Spread / Average Target

+6.13%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Industrial Biotechnology Chemicals

	1st Jan change	Capi.
NOVONESIS A/S	+15.14%	29.17B
CATHAY BIOTECH INC.	-22.68%	3.41B
BORREGAARD ASA	+11.09%	1.76B
PUYANG HUICHENG ELECTRONIC MATERIAL CO., LTD.	-22.23%	554M
HENAN JINDAN LACTIC ACID TECHNOLOGY CO.,LTD.	-32.57%	361M
BIO-ON S.P.A.	-81.65%	216M
CHEMCON SPECIALITY CHEMICALS LIMITED	-9.64%	116M

Industrial Biotechnology Chemicals

Novonesis A/S

Equities

NSIS B

DK0060336014

Specialty Chemicals

Novozymes and Chr. Hansen receive binding tax ruling that the proposed merger can be completed as a tax-exempt merger

Latest news about Novonesis A/S

Chart Novonesis A/S

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Novonesis A/S

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Industrial Biotechnology Chemicals